Slider

slide 23 to 28 of 12

Cognizant Accuses Infosys of Trade Secret Theft Related to Its Healthcare Software

Infosys denied these allegations, stating that the information was publicly available and countersued Cognizant, accusing its CEO, Ravi Kumar S
Cognizant Accuses Infosys of Trade Secret Theft Related to Its Healthcare Software

Cognizant has accused Infosys of stealing trade secrets related to its healthcare software, TriZetto. The legal battle between the two IT giants has intensified, with Cognizant claiming that Infosys was "caught red-handed" misappropriating confidential information. Infosys has denied these allegations, stating that the information in question was publicly available.

The lawsuit between Cognizant and Infosys has been filed in a federal court in Dallas, Texas. The legal battle has intensified with both companies accusing each other of various wrongdoings related to trade secrets and anti-competitive practices.

The legal dispute between Cognizant and Infosys began in August 2024 when Cognizant accused Infosys of stealing trade secrets related to its healthcare software, TriZetto. Cognizant claimed that Infosys misappropriated confidential information that it had originally accessed through non-disclosure agreements (NDAAs).

Infosys denied these allegations, stating that the information was publicly available and countersued Cognizant, accusing its CEO, Ravi Kumar S, of delaying the rollout of Infosys's own healthcare software product when he was a president at Infosys.

The dispute intensified when Cognizant alleged that Infosys refused to allow an audit of its use of TriZetto information, which could have revealed crucial evidence. Cognizant has requested the court to compel Infosys to submit all related documents. The outcome of this case could have significant implications for both companies in the global IT industry.

Cognizant's latest filing on February 7, 2025, follows Infosys's countersuit filed in January 2025. In its January countersuit, Infosys accused Cognizant and its CEO, Ravi Kumar S, of delaying the rollout of Infosys's healthcare software product, Helix, while he was still a president at Infosys. Infosys claimed that Cognizant engaged in anti-competitive practices and misused sensitive information.

Cognizant's February 7 filing reiterated its accusations that Infosys was "caught red-handed" misappropriating trade secrets related to its healthcare software, TriZetto. Cognizant also alleged that Infosys refused to allow an audit of its use of TriZetto information, which could have revealed crucial evidence.

It may be recalled that there have been similar disputes between Cognizant and Infosys in the past. The current legal battle is part of a long-standing rivalry between the two IT giants. The conflict initially began when Infosys accused Cognizant of poaching its senior executives, following the appointment of Infosys’ former president and deputy COO, Ravi Kumar S, as Cognizant’s CEO. Cognizant has also faced similar poaching allegations from another Indian IT giant, Wipro.
Like this content? Sign up for our daily newsletter to get latest updates.
0 0
both, mystorymag

DON'T MISS

Health & Wellness, Climate Change, Environment